The δ-opioid receptor regulates activity of ryanodine receptors in the human neuroblastoma cell line SK-N-BE

Journal of Neurochemistry

Volumn 67, Issue 6, 1996, Pages 2461-2470

  Allouche, Stéphane ^a   Polastron, Jocelyne ^a   Jauzac, Philippe ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

Human neuroblastoma; Intracellular Ca2+ stores; Ryanodine receptors; Thapsigargin; Opioid receptors

Indexed keywords

OPIATE AGONIST; RYANODINE RECEPTOR; SIGMA OPIATE RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL;

EID: 0029805116     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67062461.x     Document Type: Article

References (51)

1. Alvarez R. and Daniels D. V. (1991) A separation method for the assay of adenylyl cyclase, intracellular cyclic AMP and cyclic-AMP phosphodiesterase using tritium-labeled substrates. Anal. Biochem. 203, 76-82.
2. Attali B., Saya D., and Vogel Z. (1989) κ-Opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord. J. Neurochem. 52, 360-369.
3. Berridge M. J. (1993a) Inositol trisphosphate and calcium signaling. Nature 361, 315-325.
4. Berridge M. J. (1993b) A tale of two messengers. Nature 365, 388-389.
5. 2+ pools. Selective modifications by thapsigargin. J. Biol. Chem. 266, 8801-8806.
6. Buck E., Zimanyi I., Abramson J. J., and Pessah I. N. (1992) Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel. J. Biol. Chem. 267, 23560-23567.
7. 2+ channels to release adenosine from spinal cord synaptosomes. J. Neurochem. 60, 894-901.
8. Chavkin C., Neumaier J. F., and Swaerengen E. (1988) Opioid receptor mechanism in the rat hippocampus. Natl. Inst. Drug Abuse Res. Monogr. Ser. 82, 94-117.
9. Chen K. F. and Huang L. M. (1991) Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ-opioid. Neuron 7, 319-326.
10. Chen Y., Mesteh A., Liu J., and Yu L. (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
11. Childers S. R. (1991) Opioid receptor-coupled second messenger systems. Life Sci. 48, 1991-2003.
12. Connor M. and Henderson G. (1996) δ- and μ-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 117, 333-340.
13. Crain S. M. and Shen K. F. (1990) Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11, 77-81.
14. Dascal N., Lim N. F., Schreibmayer W., Wang W., Davidson N., and Lester H. A. (1993) Expression of an atrial G-protein-activated potassium channel in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 90, 6596-6600.
15. Evans C. J., Keith D. E. J., Morrison H., Magendzo K., and Edwards R. H. (1992) Cloning of delta opioid receptor by functional expression. Science 258, 1952-1955.
16. Freedman S. B., Dawson G., Villereal M. L., and Miller R. J. (1984) Identification of and characterization of voltage-sensitive calcium channels in neuronal clonal cell lines. J. Neurosci. 4, 1453-1467.
17. Grynkiewicz G., Poenie M., and Tsien R. Y. (1985) A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
18. o regulates neuronal calcium channels. Nature 325, 445-447.
19. Jenden D. J. and Fairnurst A. S. (1969) The pharmacology of ryanodine. Pharmacol. Rev. 21, 1-25.
20. Jin W., Lee N. M., Loh H. H., and Thayer S. A. (1992) Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma NG108-15 cells. Mol. Pharmacol. 42, 1083-1089.
21. Jin W., Lee N. M., Loh H. H., and Thayer S. A. (1993) Opioid inhibition of voltage-gated calcium channels parallels expression of ω-conotoxin-sensitive channel subtypes during differentiation of NG 108-15 cells. Brain Res. 602, 17-22.
22. Jin W., Lee N. M., Loh H. H., and Law P. Y. (1994) Opioids mobilize calcium from inositol 1,4,5-triphosphate sensitive stores in NG108-15 cells. J. Neurosci. 14, 1920-1929.
23. Kieffer B. L., Befort K., Gaveriaux-Ruff C., and Hirth C. G. (1992) The δ-opioid receptor isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89, 12048-12052.
24. 2+ release channel complex of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 264, 16776-16785.
25. Lowry O. H., Rosebrough N. J., Fair A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
26. MacDonald R. L. and Wertz M. A. (1986) Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurons. J. Physiol. (Lond.) 377, 237-249.
27. 2+ release channel. J. Biol. Chem. 268, 13765-13768.
28. North R. (1986) Opioid receptor types and membrane ion channels. Trends Neurosci. 9, 114-117.
29. Pan Z. Z., Williams J. T., and Osborne P. B. (1990) Opioid action on single nucleus raphe magnus neurons from rat and guinea pig in vitro. J. Physiol. (Lond.) 427, 519-532.
30. Periyasami S. and Hoss W. (1990) Kappa opioid receptors stimulate phosphoinositide turnover in rat brain. Life Sci. 47, 219-225.
31. 2+ channels and adenylyl cyclase modulation by cloned μ-opioid receptors in GH3 cells. Mol. Pharmacol. 47, 1041-1049.
32. Polastron J. and Jauzac P. (1994) Different subtypes of opioid receptors have different affinities for G-proteins. Cell. Mol. Biol. 40, 389-401.
33. Polastron J., Boyer M.-J., Quertermont Y., Thouvenot J.-P., Meunier J.-C., and Jauzac P. (1990) μ-Opioid receptors and not K-opioid receptors are coupled to the adenylate cyclase in the cerebellum. J. Neurochem. 54, 562-570.
34. Polastron J., Mur M., Mazarguil H., Puget A., Meunier J.-C., and Jauzac P. (1994) SK-N-BE: a human neuroblastoma cell line containing two subtypes of δ-opioid receptors. J. Neurochem. 62, 898-906.
35. 2+ transport ATPase by thapsigargin at subnanomolar concentrations. J. Biol. Chem. 266, 13503-13506.
36. 2+ currents, but spares a sustained current. Neuron 6, 13-20.
37. Sharma S. K., Niremberg M., and Klee W. A. (1975) Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA 72, 590-594.
38. Shen K. F. and Crain S. M. (1989) Dual opioid regulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491, 227-242.
39. Shen K. F. and Crain S. M. (1990a) Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance. Neuropharmacology 29, 343-349.
40. Shen K. F. and Crain S. M. (1990b) Cholera toxin-A blocks opioid excitatory effects on sensory neuron action potential indicating mediation by G, linked opioid receptors. Brain Res. 531, 1-7.
41. Smart D., Smith G., and Lambert D. G. (1995) μ-Opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening. Biochem. J. 305, 577-582.
42. 2+ release mechanism in bovine adrenal chromaffin cells. J. Biol. Chem. 266, 19150-19153.
43. Steine-Martin A., Mattson M., and Hauser K. F. (1993) Opiates selectively increase intracellular calcium in developing type-1 astrocytes: role of calcium in morphine-induced morphologic differentiation. Dev. Brain Res. 76, 189-196.
44. Suarez-Roca H. and Maixner W. (1993) Activation of kappa opioid receptors by U 50488 H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J. Pharmacol. Exp. Ther. 264, 648-653.
45. Takemura H., Hugues A. R., Thastrup O., and Putney J. W. Jr. (1989) Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar gland. J. Biol. Chem. 264, 12266-12271.
46. Tang T., Kiang J. G., and Cox B. M. (1994) Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells. J. Pharmacol. Exp. Ther. 270, 40-46.
47. 2+ stores by a specific inhibition of the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 87, 2466-2470.
48. + channel current by a μ-type opioid receptor. Mol. Pharmacol. 46, 793-798.
49. 5]enkephalin release requires activation of cholinergic receptors: possible involvement of intracellular calcium. Proc. Natl. Acad. Sci. USA 89, 1978-1982.
50. Yasuda K., Raynor K., Kong H., Breder C. D., Takeda J., Reisine T., and Bell G. I. (1993) Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90, 6736-6740.
51. Yu V. C. and Sadee W. (1986) Phosphatidylinositol turnover in neuroblastoma cells: regulation by bradykinin, acetylcholine but not μ- and δ-opioid receptors. Neurosci. Lett. 71, 219-223.